Catawba Capital Management’s Medtronic MDT Stock Holding History

Catawba Capital Management’s Portfolio MDT Stock Details MDT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	$1.22M	Buy	14,221 +1,399	+11%	+$117K	0.29%	82
2018 Q1	$1.03M	Sell	12,822 -791	-6%	-$65.2K	0.25%	87
2017 Q4	$1.1M	Sell	13,613 -230	-2%	-$18.4K	0.25%	85
2017 Q3	$1.08M	Sell	13,843 -825	-6%	-$68.5K	0.24%	90
2017 Q2	$1.3M	Buy	14,668 +726	+5%	+$61.2K	0.3%	81
2017 Q1	$1.12M	Hold	13,942	–	–	0.25%	97
2016 Q4	$993K	Sell	13,942 -35	-0.3%	-$2.75K	0.23%	107
2016 Q3	$1.21M	Hold	13,977	–	–	0.29%	91
2016 Q2	$1.21M	Hold	13,977	–	–	0.29%	88
2016 Q1	$1.05M	Sell	13,977 -801	-5%	-$60.3K	0.27%	94
2015 Q4	$1.14M	Buy	14,778 +865	+6%	+$65.1K	0.31%	84
2015 Q3	$931K	Buy	13,913 +56	+0.4%	+$4.12K	0.25%	93
2015 Q2	$1.03M	Buy	13,857 +79	+0.6%	+$6.04K	0.24%	95
2015 Q1	$1.07M	Buy	13,778 +7,615	+124%	+$577K	0.25%	94
2014 Q4	$445K	Buy	+6,163	New	+$428K	0.1%	158

Other funds holding MDT

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Lazard Asset Management New York $66.1B AUM 33.53% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Catawba Capital Management's MDT Position: Q2 2018 in Review

Catawba Capital Management increased its Medtronic (MDT) stake by 11% in Q2 2018, buying an estimated $117K and bringing the position to 14,221 shares worth $1.22M. The position accounts for 0.29% of the portfolio, ranked #82.

Catawba Capital Management first reported a position in MDT in Q4 2014 and has held it in 15 quarters since. The position peaked at $1.3M in Q2 2017. 1,409 funds tracked by Wall St. Rank hold MDT as of Q2 2018.

Catawba Capital Management held 14,221 shares of Medtronic worth $1.22M as of Q2 2018.
Catawba Capital Management bought 1,399 Medtronic shares in Q2 2018, an estimated $117K.
Medtronic made up 0.29% of Catawba Capital Management's portfolio in Q2 2018, its #82 holding.
Catawba Capital Management first reported a position in Medtronic in Q4 2014 and has held it in 15 quarters since.
Catawba Capital Management's Medtronic position peaked at $1.3M in Q2 2017.
1,409 funds tracked by Wall St. Rank held Medtronic as of Q2 2018.

Based on Catawba Capital Management's 13F filing for Q2 2018, filed 11 Jul 2018.